Ignite Creation Date:
2024-05-06 @ 10:21 AM
Last Modification Date:
2024-10-26 @ 12:29 PM
Study NCT ID:
NCT03237312
Status:
COMPLETED
Last Update Posted:
2017-08-02
First Post:
2017-07-30
Brief Title:
Serum Anti-mullerian Hormone and Polycystic Ovarian Syndrome
Sponsor:
Assiut University
Organization:
Assiut University
Study Overview
Official Title:
The Impact of Serum Antimullerian Hormone Level on Adjusting the Number of Ovarian Drills in Polycystic Ovarian Syndrome
Status:
COMPLETED
Status Verified Date:
2017-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In 1935 the polycystic ovary syndrome was a clinical diagnosis made on the morphological appearance of the ovaries in association with amenorrhoea hirsutism and frequently obesity At that time wedge resection of the ovaries was introduced on an empirical basis and proved a successful treatment for the associated anovulation and infertility In the ensuing fifty years the limitations of a purely surgical approach to therapy have become recognized and the importance of the biochemical abnormalities appreciated Prevalence of polycystic Ovary Syndrome The prevalence of polycystic ovary syndrome in any specified population is dependent upon the diagnostic criteria used but does have some regional and ethnic variation While most reports on the prevalence of polycystic ovary syndrome range between 2 and 20 the chosen diagnostic criteria are recognized to influence the determined prevalence Anti-mullerian hormone which is a predictor of ovarian reserve is known to decrease after laparoscopic ovarian drilling On the best of our knowledge no study had been done to use the level of anti-mullerian hormone as a factor for planning the number of ovarian drills in each ovary
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None